Tofacitinib 5 MG: Clinical Trials

4 trials of Tofacitinib 5 MG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 enrolling by invitation, 1 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Recruiting 2, Enrolling by invitation 1, Unknown 1

Follow Tofacitinib 5 MG: new trials by email Literature Review of Tofacitinib 5 MG trials Research Report on Tofacitinib 5 MG

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL
Tofacitinib 5 MG - Rheumatoid Arthritis, Major Adverse Cardiac Events
Phase 4RecruitingShaikh Zayed Hospital, Lahore1202025-12-062026-04-28
3T Therapy in the Treatment of MDA5-positive Dermatomyositis
Tofacitinib 5 MG - Dermatomyositis
Phase 4Enrolling by invitationSecond Affiliated Hospital, Zhejiang University, School of Medicine1332024-03-192024-06-03
ToFAcitinib in Early Active Axial SpondyloarThritis:
Tofacitinib 5 MG - Axial Spondyloarthritis
Phase 4RecruitingCharite University, Berlin, Germany1042023-11-102024-11-26
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
Adalimumab Injection, Tofacitinib 5 MG - Takayasu Arteritis
Phase 4UnknownChinese SLE Treatment And Research Group1002022-01-052023-07-24

Conditions studied

Arthritis, Rheumatoid (1)  ·  Axial Spondyloarthritis (1)  ·  Cardiovascular Diseases (1)  ·  Dermatomyositis (1)  ·  Takayasu Arteritis (1)

Sponsors

Charite University, Berlin, Germany (1)  ·  Chinese SLE Treatment And Research Group (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Shaikh Zayed Hospital, Lahore (1)

Countries

China (2)  ·  Germany (1)  ·  Pakistan (1)

Top investigators

Aflak Rasheed, FCPS (1)  ·  Denis Poddubbnyy, Prof. Dr. med. (1)  ·  Maira Khalil, MBBS (1)  ·  Masooma Hashmat, FCPS (1)  ·  Xiaofeng Zeng, MD (1)

Results publications

PMID 40078463